Callodine Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ares Management
ARES
|
+$6.79M |
| 2 |
Sally Beauty Holdings
SBH
|
+$4.61M |
| 3 |
Newmont
NEM
|
+$2.31M |
| 4 |
PNNT
Pennant Park Investment Corp
PNNT
|
+$1.98M |
| 5 |
Vistra
VST
|
+$1.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$8.87M |
| 2 |
Radian Group
RDN
|
+$7.69M |
| 3 |
Verizon
VZ
|
+$4.31M |
| 4 |
Comcast
CMCSA
|
+$3.93M |
| 5 |
FirstEnergy
FE
|
+$3.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 43.15% |
| 2 | Consumer Staples | 14.11% |
| 3 | Healthcare | 13.85% |
| 4 | Consumer Discretionary | 8.45% |
| 5 | Communication Services | 6.01% |
Similar funds
Callodine Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Callodine Capital Management held 45 positions worth $207M, up 10% from $188M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Callodine Capital Management withdrew a net $12.6M in Q4 2020, closing 7 positions and reducing 12 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $8.87M position sold in full.
By sector, the portfolio is most concentrated in Financials at 43% of assets, up from 37% a quarter earlier, followed by Consumer Staples and Healthcare.
Against the trend, Callodine Capital Management opened a new position in Sally Beauty Holdings worth $5.63M.
- Callodine Capital Management's largest Q4 2020 buy was Sally Beauty Holdings: 431,514 shares worth $5.63M.
- Callodine Capital Management added most to Ares Management in Q4 2020, an estimated $6.79M increase.
- Callodine Capital Management's biggest Q4 2020 reduction was Radian Group, cutting an estimated $7.69M.
- Callodine Capital Management fully exited Alexion Pharmaceuticals in Q4 2020, selling an estimated $8.87M.
- Callodine Capital Management's ten largest holdings make up 54% of its $207M portfolio in Q4 2020.
- Callodine Capital Management opened 5 new positions and closed 7 in Q4 2020.
- Callodine Capital Management's portfolio value rose 10% quarter-over-quarter to $207M.
Based on Callodine Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.